|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 03:45PM
|
|
Re: Term sheet and enterprise valuation
|
2
|
Zenith Epigenetics
|
Dec 14, 2020 06:32AM
|
|
Financials
|
2
|
Zenith Epigenetics
|
Oct 28, 2020 10:29AM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 01:56PM
|
|
Trial
|
2
|
Zenith Epigenetics
|
Nov 21, 2019 12:54PM
|
|
Guess I was wrong
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 08:52AM
|
|
Zenith
|
2
|
Resverlogix Corp.
|
Nov 21, 2019 12:58PM
|
|
Re: Re San fran
|
2
|
Resverlogix Corp.
|
Oct 19, 2020 01:34PM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 04:14PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Aug 06, 2020 02:44PM
|
|
Re: thanks Bear, was so darn excited :) I couldn't get it posted right..
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 08:41AM
|
|
Finance
|
2
|
Resverlogix Corp.
|
Mar 03, 2020 09:05AM
|
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 24, 2020 08:25AM
|
|
Re: Question
|
2
|
Resverlogix Corp.
|
Feb 25, 2021 11:01AM
|
|
Finance
|
2
|
Resverlogix Corp.
|
Dec 11, 2019 03:28PM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Apr 21, 2020 09:47AM
|
|
Re: Promissory Note
|
2
|
Zenith Epigenetics
|
Jan 31, 2021 07:36PM
|
|
Re: Dr. Ray versus Donald McCaffrey - A huge disconnect...
|
2
|
Resverlogix Corp.
|
Nov 20, 2019 07:28AM
|
|
Re: Expectations for the AGM?
|
2
|
Zenith Epigenetics
|
Dec 10, 2020 01:51PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 09:54AM
|
